title: Thymic neuroendocrine tumors.
abstract: Thymic neuroendocrine tumors are rare and account for approximately 2% to 5% of all thymic tumors. Despite the suggestion of benign behavior implied by their name, thymic carcinoids have been noted to present a more aggressive biologic behavior than their counterparts in other sites. Because of the lack of data, adequate-sized prospective trials are required for validation, and the enrollment of patients with advanced disease into available clinical trials is encouraged.
authors: Department of Thoracic Surgery, University of Torino, Via Genova 3, Torino 10126, Italy.
authors: Paolo Olivo
authors: PO
authors: Lausi
authors: Unit of Thoracic Surgery, Ospedali Riuniti, Via Conca 1, Ancona 60120, Italy.
authors: Majed
authors: M
authors: Refai
authors: Department of Thoracic Surgery, University of Torino, Via Genova 3, Torino 10126, Italy.
authors: Pier Luigi
authors: PL
authors: Filosso
authors: Department of Thoracic Surgery, University of Torino, Via Genova 3, Torino 10126, Italy.
authors: Enrico
authors: E
authors: Ruffini
authors: Department of Thoracic Surgery, University of Torino, Via Genova 3, Torino 10126, Italy.
authors: Alberto
authors: A
authors: Oliaro
authors: Department of Thoracic Surgery, University of Torino, Via Genova 3, Torino 10126, Italy.
authors: Francesco
authors: F
authors: Guerrera
authors: Department of Thoracic Surgery, St James University Hospital, Beckett Street, Leeds LS9 7TF, UK. Electronic address: alexit_2000@yahoo.com.
authors: Alessandro
authors: A
authors: Brunelli
mesh_terms: D006801:Humans; D018358:Neuroendocrine Tumors / Q000175:diagnosis / Q000628:therapy; D013945:Thymoma / Q000175:diagnosis / Q000628:therapy; D013953:Thymus Neoplasms / Q000175:diagnosis / Q000628:therapy
keywords: Chemotherapy; Neuroendocrine tumors; Outcome; Radiotherapy; Surgery; Thymus